Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/19496| Title: | Paclitaxel and bevacizumab as first line combined treatment in patients with metastatic breast cancer: the Hellenic Cooperative Oncology Group experience with biological marker evaluation |
| Institution and School/Department of submitter: | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής |
| Keywords: | Adult,Aged,Aged, 80 and over,Antibodies, Monoclonal/administration & dosage,Antibodies, Monoclonal, Humanized,Antineoplastic Combined Chemotherapy Protocols/administration &,dosage/*therapeutic use,Breast Neoplasms/*drug therapy/metabolism/pathology,Female,Humans,In Situ Hybridization, Fluorescence,Middle Aged,Neoplasm Metastasis,Paclitaxel/administration & dosage,Retrospective Studies,Tumor Markers, Biological/*metabolism |
| URI: | https://olympias.lib.uoi.gr/jspui/handle/123456789/19496 |
| ISSN: | 1791-7530 |
| Link: | http://www.ncbi.nlm.nih.gov/pubmed/21868552 |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License
